JP Morgan Chase’s Transphorm, Inc. Common Stock TGAN Stock Holding History

JP Morgan Chase’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-54,417	Closed	-$267K	–	7835
2024 Q1	$267K	Buy	54,417 +22,645	+71%	+$107K	﹤0.01%	5185
2023 Q4	$116K	Buy	31,772 +14,249	+81%	+$39K	﹤0.01%	5663
2023 Q3	$38.9K	Sell	17,523 -104,518	-86%	-$292K	﹤0.01%	5876
2023 Q2	$415K	Sell	122,041 -131,798	-52%	-$475K	﹤0.01%	4604
2023 Q1	$1.01M	Buy	253,839 +240,961	+1,871%	+$1.06M	﹤0.01%	4034
2022 Q4	$70K	Buy	12,878 +544	+4%	+$3.2K	﹤0.01%	5491
2022 Q3	$62K	Buy	12,334 +868	+8%	+$4.27K	﹤0.01%	5474
2022 Q2	$44K	Sell	11,466 -9,234	-45%	-$59K	﹤0.01%	5702
2022 Q1	$146K	Buy	+20,700	New	+$145K	﹤0.01%	5342

JP Morgan Chase's TGAN Position: Q2 2024 in Review

JP Morgan Chase sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 54,417 shares — an estimated $267K sold.

JP Morgan Chase first reported a position in TGAN in Q1 2022 and held it in 9 quarters. The position peaked at $1.01M in Q1 2023. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

JP Morgan Chase reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
JP Morgan Chase sold 54,417 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $267K.
JP Morgan Chase first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
JP Morgan Chase's Transphorm, Inc. Common Stock position peaked at $1.01M in Q1 2023.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.